Skip to main content

Table 1 Characteristics of the included studies

From: The Association of obesity with vascular complications after liver transplantation

Reference Region Sample Size Periods Recipient Age MELD Score Male (%) Most common etiology
BMI ≥ 30 BMI < 30 BMI ≥ 30 BMI < 30
Nair (2001)a [15] America 21Φ 64b 1994-1996 46.7 ± 10.5Φ 46.0 ± 12.6b / 82.4 HCV
Fujikawa (2006) [21] America 167 533 1990–2005 51.0 ±? 49.5 ±? 18.5 ±? 61.3 /
Lamattina (2012) [13] America 306 482 1997–2008 53.4 ± 8.8 52.6 ± 9.9 19.8 ± 8.8 63.1 Alcohol
Hakeem (2013) [16] The UK 218 1107 1994–2009 50.9 ± 8.5 47.4 ± 13.0 19.7 ± 10.7 56.9 cholestasis
Tanaka (2013) [22] Canada 149 358 2000–2006 52.9 ± 8.6 51.4 ± 10.5 16.2 ± 8.0 69.0 HCV
Gunay (2013) [23] Europe 74 296 2004–2012 52.4 ± 8.4 50.4 ± 11.3 16.7 ± 6.6 76.8 HBV
Triguero (2015)a [24] Europe 11(BMI > 35) 36(BMI 20–25) 2007–2013 53 ±?(45–64) 54.5 ±? 15 ±? 78.7 Alcohol
Molina (2016) [14] Europe 73 135 2008–2014 54.8 ± 7.7 52.8 ± 10.3 18.2 ± 5.0 84.1 Alcohol
  1. aThese studies were not included because of inconsistent grouping with others. Φ: BMI > 31.1 for men and 32.3 for women
  2. bBMI < 27.8 for men and < 27.3 for women; MELD: model for end-stage liver disease; HBV: hepatic B virus; HCV: hepatic C virus